Search - tctmd.com

Displaying 221 - 240 of 940

Sort: Relevancy | Date

News Opinion Conversations in Cardiology

Conversations in Cardiology: Should Interventional Cardiologists Get Paid for Being On Call?

November 08, 2019

News Daily News

Repeat Target-Lesion PCI: An Option for Public Reporting?

Michael O'Riordan

October 25, 2019

News Conference News TCT 2019

Ultrathin-Strut Orsiro Stent as Good as BioMatrix: BIODEGRADE

Michael O'Riordan

September 30, 2019

Presentation TCT 2019

Role of New-Gen DES in Patients at HBR: Does Stent Type Matter?

Presenter: Ajay Kirtane

September 28, 2019

Presentation TCT 2019

CTO PCI 2019 Literature Update

Presenter: Ajay Kirtane

September 28, 2019

Presentation TCT 2019

Update on RADIANCE Trials Program (Ultra-Sound Renal Denervation): Lessons Learned, Ongoing Efforts

Presenter: Ajay Kirtane

September 28, 2019

Presentation TCT 2019

Treatment of Severely Calcified Lesions: The Need for Comparative Data

Presenter: Ajay Kirtane

September 28, 2019

News Conference News TCT 2019

Surgical Volume Matters When It Comes to Repair of Primary MR

Todd Neale

September 28, 2019

Presentation TCT 2019

The Evolving SYNERGY Programs: EVOLVE-Short DAPT Updates

Presenter: Ajay Kirtane

September 28, 2019

Presentation TCT 2019

Session II: Coronary Artery Calcium - Keep Your Eyes Open: Insights Into the Treatment of Coronary Calcium

Presenter: Ajay Kirtane

September 27, 2019

News Conference News TCT 2019

SCOPE I: Acurate Neo Comes Up Short for Severe Aortic Stenosis

Marcus A. Banks

September 27, 2019

News Conference News TCT 2019

Leaflet Thickening and Impaired Motion No Worse With TAVR: PARTNER 3 CT

Michael O'Riordan

September 27, 2019

Presentation TCT 2019

RADIANCE-HTN SOLO: In-Depth Analysis at 6 Months After Medication Titration and Review of RADIANCE-HTN Global Clinical Trial Program

Presenter: Ajay Kirtane

September 27, 2019

Presentation TCT 2019

Introduction to Session

Presenter: Ajay Kirtane

September 27, 2019

News Conference News TCT 2019

Transseptal Transcatheter Mitral Valve-in-Valve Ups Survival in High-Risk Patients

Yael L. Maxwell

September 27, 2019

Presentation TCT 2019

Clinical Insights: The Evidence and Technique Behind Orbital Atherectomy

Presenter: Ajay Kirtane

September 27, 2019

Presentation TCT 2019

Short and Optimal DAPT: Lessons From the EVOLVE SHORT-DAPT Late Breaking Science

Presenter: Ajay Kirtane

September 27, 2019

Presentation TCT 2019

EVOLVE/ LEADERS Short DAPT Programs

Presenter: Ajay Kirtane

September 27, 2019

News Conference News TCT 2019

Safe to Drop P2Y12 Inhibitor at 3 Months in High-Bleeding-Risk Patients: EVOLVE Short DAPT

Caitlin E. Cox

September 26, 2019

News TCT 2019

TCT 2019 Day One: TWILIGHT and Onyx ONE Kick Things Off

Shelley Wood

September 26, 2019

Advertisement

Conversations in Cardiology: Should Interventional Cardiologists Get Paid for Being On Call?

Repeat Target-Lesion PCI: An Option for Public Reporting?

Ultrathin-Strut Orsiro Stent as Good as BioMatrix: BIODEGRADE

Role of New-Gen DES in Patients at HBR: Does Stent Type Matter?

CTO PCI 2019 Literature Update

Update on RADIANCE Trials Program (Ultra-Sound Renal Denervation): Lessons Learned, Ongoing Efforts

Treatment of Severely Calcified Lesions: The Need for Comparative Data

Surgical Volume Matters When It Comes to Repair of Primary MR

The Evolving SYNERGY Programs: EVOLVE-Short DAPT Updates

Session II: Coronary Artery Calcium - Keep Your Eyes Open: Insights Into the Treatment of Coronary Calcium

SCOPE I: Acurate Neo Comes Up Short for Severe Aortic Stenosis

Leaflet Thickening and Impaired Motion No Worse With TAVR: PARTNER 3 CT

RADIANCE-HTN SOLO: In-Depth Analysis at 6 Months After Medication Titration and Review of RADIANCE-HTN Global Clinical Trial Program

Introduction to Session

Transseptal Transcatheter Mitral Valve-in-Valve Ups Survival in High-Risk Patients

Clinical Insights: The Evidence and Technique Behind Orbital Atherectomy

Short and Optimal DAPT: Lessons From the EVOLVE SHORT-DAPT Late Breaking Science

EVOLVE/ LEADERS Short DAPT Programs

Safe to Drop P2Y12 Inhibitor at 3 Months in High-Bleeding-Risk Patients: EVOLVE Short DAPT

TCT 2019 Day One: TWILIGHT and Onyx ONE Kick Things Off

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content